about
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitusEmerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetesThe Effect of Sitagliptin on Lipid Metabolism of Fatty Liver Mice and Related Mechanisms.Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.Incretin therapies in the management of patients with type 2 diabetes mellitus and renal impairment.Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus.Looking to the future: focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapies.The potential role of vildagliptin in the management and prevention of type 2 diabetes mellitus.
P2860
Q24243196-BFE93878-FDB1-4BBA-82FD-4C1607A7A38EQ28762629-981D6DE0-2218-4AD8-8FD9-205D535A5043Q37726145-8EA4BF0A-6F29-47BE-911C-BA72F21CB8E3Q37735838-BF987EB9-0910-4F72-9A76-4E4903B0014FQ38012068-1BBF0E0A-B659-476E-838C-094A51B166EAQ38546981-00D8A51B-C6A5-4ABC-85A8-463EA1D99808Q40108641-9A2687D0-B168-4F66-A7EC-0249D60EC243Q42575070-B0EBC4B1-7A15-4B13-9F63-E520CC6CAF59
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Vildagliptin.
@ast
Vildagliptin.
@en
type
label
Vildagliptin.
@ast
Vildagliptin.
@en
prefLabel
Vildagliptin.
@ast
Vildagliptin.
@en
P1433
P1476
Vildagliptin.
@en
P2093
Sheridan Henness
Susan J Keam
P304
1989-2001; discussion 2002-4
P356
10.2165/00003495-200666150-00007
P577
2006-01-01T00:00:00Z
P6179
1008711994